Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marshall Edwards has entered into a securities subscription agreement with Novogen and OppenheimerFunds pursuant to which the company has sold 2.90 million and 1.7 million shares of common stock, par value $0.00000002 per share, to Novogen and Oppenheimer, respectively, at a purchase price of $2.17 per share.
Subscribe to our email newsletter
The aggregate proceeds to Marshall Edwards from the sale of shares of common stock will be $10 million before expenses.
The shares are registered under the Securities Act of 1933, as amended, pursuant to an effective shelf registration statement.